Opaleye Management Inc.'s Form 4 filing
Tracon Pharmaceuticals, Inc. (TCON) · filed Apr 12, 2022
- Accession no.
- 0001493152-22-009735
- Filed
- Apr 12, 2022
- Trade date
- Apr 11-12, 2022
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions. Open-market purchases total $66.9K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Opaleye Management Inc.CIK 0001595855 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 11, 2022 | Common Stock, par value $0.001 per share | PPurchaseAcquired | +6,463 | $2.42F3 | +$15,640.46 | 2,844,198 | Indirect | |
| Apr 11, 2022 | Common Stock, par value $0.001 per share | PPurchaseAcquired | +2,637 | $2.42F3 | +$6,381.54 | 320,000 | Indirect | |
| Apr 12, 2022 | Common Stock, par value $0.001 per share | PPurchaseAcquired | +13,098 | $2.48F4 | +$32,483.04 | 2,857,296 | Indirect | |
| Apr 12, 2022 | Common Stock, par value $0.001 per share | PPurchaseAcquired | +5,000 | $2.48F4 | +$12,400 | 325,000 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F3
The common stock was purchased by the reporting person in open market transactions on the transaction date, with a volume weighted average purchase price of $2.4197. The range of purchase prices on the transaction date was $2.40 to $2.45 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price.
Referenced by the price of 2 transactions in Table I.
- F4
The common stock was purchased by the reporting person in open market transactions on the transaction date, with a volume weighted average purchase price of $2.4769 The range of purchase prices on the transaction date was $2.45 to $2.50 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price.
Referenced by the price of 2 transactions in Table I.